SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to a massive volume spike and price surge, triggering multiple trading halts, as community discussion focuses on its extremely low float and high insider ownership for a potential short squeeze. Many are comparing it to recent explosive SPACs, with speculative targets suggesting significant upside, fueled by talking points like a rumored "sex toy manufacturer" acquisition. The stock's momentum reflects its position as a key play in the current "SPAC mania" for micro-float tickers.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is rapidly trending due to a potent combination of its extremely low share float and a potential short squeeze, driving significant momentum. The recent announcement of a strategic manufacturing partnership, expected to boost production margins, further amplifies investor interest. The community is actively discussing strong buying defense and a "textbook" short squeeze play as the company continues to expand global adoption of its fingerprint drug screening technology.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings (ONDS) is trending due to recent autonomous system orders and the FCC's ban on foreign-made drones, which significantly boosts its role in the domestic market. The community is actively discussing a potential short squeeze and anticipating a significant price breakout, with many seeing dips as buying opportunities. This positions Ondas as a crucial player in the growing defense and critical infrastructure sectors for autonomous and counter-drone solutions.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after the FDA issued a Complete Response Letter for its relacorilant hypertension indication, triggering a sharp stock decline and intense community debate. Investors are divided, with many viewing the sell-off as an overreaction given the company's existing profitable drug and other pipeline programs, while others express caution regarding potential delays and future prospects.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending following its recent FDA approval of NEREUS, the first new motion sickness treatment in over four decades, validating a significant pipeline asset. Community discussion highlights the drug's broader potential for GLP-1 induced nausea, fueling speculation of substantial upside, a potential short squeeze, and even a buyout, given the company's strong financial standing and additional upcoming regulatory catalysts.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following its CEO's strategic insights on CNBC and news of spinning off its cloud business into ChronoScale, a move seen by many as unlocking significant value and clarifying its pure-play AI data center infrastructure focus. The community is actively discussing sustained demand from hyperscalers and strong analyst confidence ahead of its upcoming earnings report, fueling bullish sentiment despite recent price volatility. This strategic realignment aims to capitalize on the booming AI infrastructure market with a clearer business model and substantial contracted revenue.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst a wave of strong bearish sentiment, largely attributed to sustained selling pressure, high short interest, and year-end tax loss harvesting. The community is actively discussing the recent FDA approval of Novo Nordisk's oral Wegovy pill, seeing a potential for partnership and a significant catalyst for HIMS's future growth in GLP-1 offerings, alongside its ongoing expansion in D2C lab testing and international markets. Despite current frustration, many long-term investors are using this dip as a buying opportunity, anticipating a strong reversal.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after rival Corcept Therapeutics received an FDA Complete Response Letter for its Cushing's syndrome drug, effectively removing a near-term competitor for Xeris's Recorlev. The community is buzzing with bullish sentiment, emphasizing Recorlev's blockbuster potential and the significant undervaluation of XERS, further supported by advancing pipeline assets like XP-8121 and robust gross margins.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to the FDA's acceptance and priority review of its supplemental New Drug Application for AXS-05 in Alzheimer's disease agitation, with an action date anticipated in the near future. This significant regulatory milestone, combined with growing sales of its existing CNS therapies like Auvelity, has ignited immense optimism within the community, with many anticipating substantial long-term value and discussing breakthrough potential.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

Motorola Solutions ($MSI) is trending following strategic acquisitions in advanced communications and AI-powered video monitoring, reinforcing its leadership in mission-critical technology for public safety and enterprise security. Community sentiment reflects a strong focus on institutional accumulation, evident in large dark pool trades and technical indicators suggesting the stock is oversold, signaling potential for a reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Small-Cap ETFs Outperform on Inflation Data

PSCI, PSCT, XSVM, XSHQ and FYT led small-cap ETF gains after softer inflation data boosted rate cut hopes.



CoreCivic (CXW) shares rose 2.4% on Thursday after Wedbush raised the stock's price target to $42 from $30.According to The Fly, the brokerage also maintained an ‘Outperform’ rating for the prison operator.The new price target implied an upside of 106.3% from the stock’s last close. According to FinChat data, the stock has a consensus price target of $30.50.Wedbush noted that high points for the stock include the award of letter contracts from the U.S. Immigration and Customs Enforcement (ICE) to CoreCivic to restart operations at the California City facility and a Midwest facility with roughly 1,000 beds.U.S. President Donald Trump has promised to implement the largest mass deportation of undocumented immigrants in U.S. history, a shift in policy that has benefited private prison operators.According to a <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.nytimes.com/2025/04/07/us/politics/trump-administration-immigrant-detention-facilities-services.html">report </a>by The New York Times, the Trump administration aims to spend $45 billion over the next two years on new detention facilities, transportation, security guards, medical support, and other administrative services.Last month, <a href="https://stocktwits.com/news-articles/markets/equity/core-civic-rises-after-agreement-to-resume-operations-at-texas-migrant-detention-facility/cheFmkVR6k">CoreCivic agreed</a> to start operations at a migrant detention facility in Texas, which is expected to generate a total annual revenue of about $180 million.Retail sentiment on Stocktwits remained in the ‘extremely bullish’ (80/100) territory, while retail chatter was ‘normal.’<figure class="image"><img style="aspect-ratio:882/208;" src="https://news.stocktwits-cdn.com/CXW_April_10_JPG_b4df64add1.webp" alt="CXW’s Sentiment Meter and Message Volume as of 10:04 p.m. ET on April 10, 2025 | Source: Stocktwits" width="882" height="208"><figcaption>CXW’s Sentiment Meter and Message Volume as of 10:04 p.m. ET on April 10, 2025 | Source: Stocktwits</figcaption></figure>The company had topped Wall Street’s quarterly profit and revenue estimates earlier in February.The Brentwood, Tennessee-based company is scheduled to report its first-quarter earnings on May 7 after the bell.<a href="https://stocktwits.com/symbol/CXW">CoreCivic shares</a> have fallen 4.2% year-to-date (YTD).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nvax-stock-tumbles-after-rfk-jr-doubts-covid-shot-efficacy/chfrP58RbBy">Novavax Retail Traders Rally In Defense After RFK Jr.'s COVID-19 Vaccine Skepticism Sends Stock Tumbling</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 A view of the CoreCivic Otay Mesa Detention Center in San Diego, California, United States on February 07, 2025. (Photo by Carlos Moreno/Anadolu via Getty Images)

Trump-Linked CoreCivic Stock Pops After Price Target Bump, Retail Bulls Emboldened  

Wedbush’s new price target implied an upside of 106.3% from the stock’s last close.

Trump-Linked CoreCivic Stock Pops After Price Target Bump

Equity

Wedbush’s new price target implied an upside of 106.3% from the stock’s last close.


Too early to buy Russell 2000, BofA says

Investing.com -- Bank of America (BofA) relayed a cautious stance on the Russell 2000, suggesting it is too early for investors to buy into the small-cap index despite the recent sell-off.

CoreCivic (CXW) stock gained 7.1% in extended trading on Wednesday after it agreed to resume operations at a migrant detention facility in Texas.The prison operator said it has signed an agreement with the U.S. Immigration and Customs Enforcement (ICE) to resume operations at the South Texas Family Residential Center in Dilley, Texas, which can house up to 2,400 people.U.S. President Donald Trump has promised to implement the largest mass deportation of undocumented immigrants in U.S. history, a shift in policy that has benefited private prison operators.The Dilley facility was purpose-built for ICE in 2014, and the company managed it from its construction through August 2024, when the Biden administration terminated funding for the contract with ICE and the facility was idled.The company said the new agreement expires in March 2030 and may be extended through bilateral modification.Once fully activated, CoreCivic expects the facility to generate total annual revenue of about $180 million, including medical services.The Brentwood, Tennessee-based company started pre-activation activities at the facility earlier this year and expects the agreement to be accretive to earnings beginning in the second quarter."We are offering our staff the opportunity to transfer to the Dilley Facility and expect many who accept transfer opportunities will be professionals who previously provided services at the facility prior to its closure last year, expediting the activation process,” Chief Operating Officer Patrick Swindle said.Retail sentiment on Stocktwits moved higher in the ‘bullish’ (63/100) territory than a day ago, while retail chatter remained ‘extremely low.’<figure class="image"><img style="aspect-ratio:727/169;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CXW_March_5_c8c159a696.JPG" alt="CXW’s Sentiment Meter and Message Volume as of 09:03 p.m. ET on March 5, 2025 | Source: Stocktwits" width="727" height="169"><figcaption>CXW’s Sentiment Meter and Message Volume as of 09:03 p.m. ET on March 5, 2025 | Source: Stocktwits</figcaption></figure>Last week, the company had signed four new contract modifications with ICE to add capacity at its detention facilities.CoreCivic also topped Wall Street’s estimates for quarterly profit and revenue earlier in February.Over the past year,<a href="https://stocktwits.com/symbol/CXW"> CoreCivic's shares</a> have gained 27.5%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/ocgn-stock-rises-after-hours-on-q4-2024-reevnue-beat/cheFkc3R6S">Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Portraits of President Donald J. Trump and former Vice President Mike Pence at the South Texas Family Residential Center on Friday, Aug 23, 2019 in Dilley, TX. (Photo by Jabin Botsford/The Washington Post via Getty Images)

CoreCivic Rises After Agreement To Resume Operations At Texas Migrant Detention Facility, Retail’s Bullish

The company said the new agreement expires in March 2030 and may be extended through bilateral modification.

The manufacturing sector has been in a recession since November 2022, according to the Institute for Supply Management’s (ISM) manufacturing purchasing managers’ index (PMI). There could be light at the end of the tunnel, with a new administration taking charge in a little under three months following Donald Trump’s convincing win in the 2024 presidential election.Down In DumpsThe ISM’s manufacturing PMI has been below the “50” cut-off mark that separates expansion and contraction for 23 months since Nov. 2022 and barely expanded in a month in the interim (March 2024).<figure class="image"><img style="aspect-ratio:1182/532;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ism_ycharts_e9baa61ddf.png" alt="ism-ycharts.png" width="1182" height="532"><figcaption>Source: Y Charts</figcaption></figure>The latest manufacturing PMI reading came in at 46.5 for October, which marked the fastest contraction since July 2023.Timothy Fiore, chair of the ISM, said,&nbsp;“U.S. manufacturing activity contracted again in October, and at a faster rate compared to last month. Demand continues to be weak, output declined, and inputs stayed accommodative.”He attributed the predicament to contractions in new orders and backlog of orders, and depressed customer inventory levels."Demand remains subdued, as companies continue to show an unwillingness to invest in capital and inventory due to concerns (for example, inflation resurgence) about federal monetary policy direction in light of the fiscal policies proposed by both major parties," Fiore said.The manufacturing sector’s contribution to GDP has been on the decline, accounting for just 10% of the total GDP in the second quarter of 2024.<figure class="image"><img style="aspect-ratio:1320/450;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/fredgraph_manufact_f106ee66ae.png" alt="fredgraph - manufact.png" width="1320" height="450"><figcaption>Source: St. Louis Fed</figcaption></figure>Revival In CardsIn a campaign speech in North Carolina in late September, Trump&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://tribune.com.pk/story/2498698/trump-promises-us-manufacturing-revival-in-north-carolina-speech">promised</a> to bring about a “manufacturing renaissance” by reducing taxes, reducing energy costs, and easing regulations to attract jobs from other countries.Fund manager Louis Navellier said in a recent note to clients that the manufacturing sector is on track to turn around.If the new administration can help the sector to expand via tariffs against unfair competition overseas and work toward lowering energy prices, and the Federal Reserve reduces rates, the U.S. manufacturing sector can gain a competitive advantage vis-a-vis the other nations, he said.“In theory, the U.S. should experience a manufacturing boom, especially if the natural gas industry booms and helps expand the U.S. utility grid,” Navellier said.Retail interest in the manufacturing sector has increased amid these geopolitical developments.&nbsp;Here are the most widely-tracked industrial stocks on Stocktwits and their watcher count:Boeing Co. ($BA): 188,825General Electric Co. ($GE): 151,848Caterpillar, Inc. ($CAT): 31,052Lockheed Martin Corp. ($LMT): 30,114Tellurian, Inc. ($TELL): 25,3733M Co. ($MMM): 23,617SunPower Corp. ($SPWR): 23,270RTX Corp. ($RTX): 20,148Deere &amp; Co. (DE): 12,158Kratos Defense &amp; Security Solutions, Inc. ($KTOS): 12,158Axon Enterprises, Inc. ($AXON): 10,969Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/altimmune-stock-gains-on-positive-regulatory-update-on-obesity-candidate/cJ45TcSRa9">Altimmune Stock Jumps As Obesity Drug Candidate Clears Key FDA Meeting: Retail Bulls Charge In</a>For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>&nbsp;

Manufacturing sector currently contribute to 10% of GDP.

Can Trump Make Manufacturing Great Again? 11 Stocks Retail Is Closely Watching

The ISM’s manufacturing PMI has been below the “50” cut-off mark that separates expansion and contraction for 23 of the 24 months since Nov. 2022

PSCI
Invesco S&P SmallCap Industrials ETF

Feed

News

Sentiment

Fundamentals

Info

Latest PSCI News

PSCIInvesco S&P SmallCap Industrials ETF